ATE286911T1 - Transkriptionsfaktor und dessen dna - Google Patents
Transkriptionsfaktor und dessen dnaInfo
- Publication number
- ATE286911T1 ATE286911T1 AT00977879T AT00977879T ATE286911T1 AT E286911 T1 ATE286911 T1 AT E286911T1 AT 00977879 T AT00977879 T AT 00977879T AT 00977879 T AT00977879 T AT 00977879T AT E286911 T1 ATE286911 T1 AT E286911T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- polypeptide
- dna
- activity
- preventives
- Prior art date
Links
- 108020004414 DNA Proteins 0.000 title 1
- 108091023040 Transcription factor Proteins 0.000 title 1
- 102000040945 Transcription factor Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 6
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 6
- 230000000694 effects Effects 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 201000010099 disease Diseases 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 3
- 230000003449 preventive effect Effects 0.000 abstract 3
- 208000010392 Bone Fractures Diseases 0.000 abstract 2
- 102400000676 Chondromodulin-1 Human genes 0.000 abstract 2
- 101800004542 Chondromodulin-1 Proteins 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 208000001132 Osteoporosis Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 201000008482 osteoarthritis Diseases 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 2
- 206010019909 Hernia Diseases 0.000 abstract 1
- 208000008765 Sciatica Diseases 0.000 abstract 1
- 230000022159 cartilage development Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
- 238000013518 transcription Methods 0.000 abstract 1
- 230000035897 transcription Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP33647599 | 1999-11-26 | ||
| PCT/JP2000/008257 WO2001038392A1 (fr) | 1999-11-26 | 2000-11-24 | Nouveau facteur de transcription et son adn |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE286911T1 true ATE286911T1 (de) | 2005-01-15 |
Family
ID=18299528
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00977879T ATE286911T1 (de) | 1999-11-26 | 2000-11-24 | Transkriptionsfaktor und dessen dna |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7241860B1 (enExample) |
| EP (1) | EP1233023B1 (enExample) |
| JP (1) | JP2001211890A (enExample) |
| AT (1) | ATE286911T1 (enExample) |
| AU (1) | AU1549701A (enExample) |
| CA (1) | CA2392351A1 (enExample) |
| DE (1) | DE60017453T2 (enExample) |
| WO (1) | WO2001038392A1 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05178896A (ja) | 1990-08-23 | 1993-07-20 | Mitsubishi Kasei Corp | 新規なタンパク質、それをコードする遺伝子及びその産生方法 |
| JP3585180B2 (ja) * | 1993-05-11 | 2004-11-04 | 三菱化学株式会社 | 新規なヒトタンパク質およびそれをコードする遺伝子 |
| US5851775A (en) * | 1997-03-20 | 1998-12-22 | Johns Hopkins University | β-catenin, Tcf-4, and APC interact to prevent cancer |
-
2000
- 2000-11-24 EP EP00977879A patent/EP1233023B1/en not_active Expired - Lifetime
- 2000-11-24 AU AU15497/01A patent/AU1549701A/en not_active Abandoned
- 2000-11-24 AT AT00977879T patent/ATE286911T1/de not_active IP Right Cessation
- 2000-11-24 CA CA002392351A patent/CA2392351A1/en not_active Abandoned
- 2000-11-24 US US10/130,872 patent/US7241860B1/en not_active Expired - Fee Related
- 2000-11-24 DE DE60017453T patent/DE60017453T2/de not_active Expired - Lifetime
- 2000-11-24 JP JP2000357232A patent/JP2001211890A/ja active Pending
- 2000-11-24 WO PCT/JP2000/008257 patent/WO2001038392A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US7241860B1 (en) | 2007-07-10 |
| EP1233023A1 (en) | 2002-08-21 |
| DE60017453T2 (de) | 2005-12-22 |
| JP2001211890A (ja) | 2001-08-07 |
| CA2392351A1 (en) | 2001-05-31 |
| WO2001038392A1 (fr) | 2001-05-31 |
| EP1233023B1 (en) | 2005-01-12 |
| DE60017453D1 (de) | 2005-02-17 |
| AU1549701A (en) | 2001-06-04 |
| EP1233023A4 (en) | 2003-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9810651A (pt) | Certos derivados de diarilimidazol; uma nova classe de ligantes npy especìficos | |
| ATE478135T1 (de) | Differenzierung in osteoblasten der fettgewebe- stromalen zellen und ihre verwendungen | |
| IL136738A0 (en) | Inhibition of p38 kinase activity using substituted heterocyclic ureas | |
| HU9500673D0 (en) | Novel rapamycin binding proteins and their diagnostic and therapeutic use | |
| AP0202538A0 (en) | Inhibitors of interleukin -1b converting enzyme. | |
| IL144144A0 (en) | Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors | |
| IL143266A0 (en) | Transforming growth factor-beta binding proteins and pharmaceutical compositions for increasing bone mineral content utilizing the same | |
| ES2151467T1 (es) | Inhibicion de la actividad de la quinasa p38 por aril-ureas. | |
| IL136768A0 (en) | INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS | |
| WO2003094835A3 (en) | Fgf variants and methods for use thereof | |
| DE69837809D1 (de) | Apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dislipidemischer erkrankungen | |
| DE69819360D1 (de) | Neue psoralene zur inaktivierung von pathogenen | |
| BR9711795A (pt) | Peptìdeos tendo propriedades antiproliferativas | |
| BR9808881A (pt) | Compostos para imunoterapia de câncer de próstata e métodos para seu uso | |
| ATE444960T1 (de) | Polyhydroxystilbene und -stilbenoxide als antipsoriasismittel und proteinkinasehemmer | |
| ATE266675T1 (de) | Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese | |
| JO2373B1 (en) | W-carboxy-aryl diphenyl urease substitutes used as RAV inhibitors | |
| AU4568901A (en) | Vertebral implant for promoting arthrodesis of the spine | |
| DE69813895D1 (de) | Phenolsulfonamide als pde-iv inhibitoren und ihre therapeutische verwendung | |
| WO1999037604A3 (en) | Dialkyl ureas as calcitonin mimetics | |
| WO1999053040A3 (de) | Menschliche nukleinsäuresequenzen aus ovartumorgewebe | |
| ATE275417T1 (de) | Verwendung von vegf-c und vegf-d genen oder proteinen zur vorbeugung der restenose | |
| DE69917317D1 (de) | Zubereitung und verwendung von rar antagonisten zur forderung der chondrogenese | |
| WO2001042243A3 (en) | Protein kinase inhibitors | |
| DE60017453D1 (de) | Transkriptionsfaktor und dessen dna |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |